Nexgel (NXGLW) Non Operating Income (2021 - 2025)
Nexgel's (NXGLW) quarterly Non Operating Income came in at $286000.0 in Q4 2025, up 1582.35% YoY from $17000.0 in Q4 2024, and up 266.67% on a QoQ basis from $78000.0 in Q3 2025.
Nexgel (NXGLW) Non Operating Income (2021 - 2025) Analysis & Trends
Nexgel (NXGLW) has 5 years of Non Operating Income data on file, last reported at $286000.0 in Q4 2025.
- Quarterly Non Operating Income rose 1582.35% year-over-year to $286000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $442000.0 (up 380.43% YoY) and the FY2025 annual result came in at $459000.0, up 404.4% from the prior year.
- Non Operating Income improved to $286000.0 in Q4 2025, from $78000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $286000.0 in Q4 2025 to a low of -$1.0 million in Q1 2022.
- A 5-year average of -$112263.2 and a median of $32000.0 in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2024 — Non Operating Income slumped 144.74% — and 2025, when it surged 1582.35%.
- Tracing NXGLW's Non Operating Income over 5 years: stood at -$752000.0 in 2021, then jumped by 117.69% to $133000.0 in 2022, then plunged by 75.94% to $32000.0 in 2023, then slumped by 46.88% to $17000.0 in 2024, then surged by 1582.35% to $286000.0 in 2025.
- The last three Non Operating Income figures came in at $286000.0 (Q4 2025), $78000.0 (Q3 2025), and -$21000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 82.70 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 25.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -160.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -12.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.50 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | -1.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 286,000.00 |
| Sep 30, 2025 | 78,000.00 |
| Jun 30, 2025 | -21,000.00 |
| Mar 31, 2025 | 99,000.00 |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 34,000.00 |
| Jun 30, 2024 | 75,000.00 |
| Mar 31, 2024 | -34,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Sep 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 120,000.00 |
| Mar 31, 2023 | 76,000.00 |
| Dec 31, 2022 | 133,000.00 |
| Sep 30, 2022 | -190,000.00 |
| Jun 30, 2022 | -317,000.00 |
| Mar 31, 2022 | -1.02 Mn |
| Dec 31, 2021 | -752,000.00 |
| Sep 30, 2021 | -532,000.00 |
| Jun 30, 2021 | -273,000.00 |